Exploring Mechanism of Enzyme Catalysis by On-Chip Transient Kinetics Coupled with Global Data Analysis and Molecular Modeling

Authors

Hess, D., Dockalova, V., Kokkonen, P., Bednar, D., Damborsky, J., deMello, A., Prokop, Z., Stavrakis, S.

Source

CHEM 7: 1066-1079 (2021)

Abstract

The ability to engineer enzymes for industrial and biomedical applications is primarily limited by a paucity of mechanistic understanding. To gain insight into the mechanisms of enzyme catalysis, one must screen enormous numbers of discrete reaction conditions, which is a laborious task using conventional technologies. To address such limitations, we develop a droplet-based microfluidic platform for high-throughput acquisition of transient kinetic data over a range of substrate concentrations and temperatures. When compared with conventional methods, our platform reduces assay volumes by six orders of magnitude and increases throughput to 9,000 reactions/min. To demonstrate their utility, we measure the transient kinetics of three model enzymes, namely, b-galactosidase, horseradish peroxidase, and microperoxidase. Additionally, we conduct a complex kinetic and thermodynamic study of engineered variants of haloalkane dehalogenases. Datasets are globally analyzed and complemented by molecular dynamics simulations, providing new insights into the molecular basis of substrate specificity and the role of hydration-related entropy.

Full text •  Supplement

Citation

Hess, D., Dockalova, V., Kokkonen, P., Bednar, D., Damborsky, J., deMello, A., Prokop, Z., Stavrakis, S., 2021: Exploring Mechanism of Enzyme Catalysis by On-Chip Transient Kinetics Coupled with Global Data Analysis and Molecular Modeling. Chem 7: 1066-1079.

5th Hands-on Computational Enzyme Design Workshop
Jiri to Present at Biocatalysis Gordon Research Conference 2024
Interview with Martin – I Came Into My Own in the Microworld
Jiri and Pavel at Symposium: Biochemical Machine Learning
Lukas at International Science and Engineering Fair in Dallas
Jiri to Present at Elixir 3D Bio AGM
Press Release: We Are Closer to Treatment of Alzheimer’s Disease